Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

SW/PSYCH
Workshop

W10--Psychosocial Research Showcase

Thursday, September 26, 2024
10:15 AM – 12:15 PM ET
Location:102 AB

Recorded Session

This session is designed to highlight current psychosocial research with a focus on innovative, relevant, and impactful projects that contribute to our understanding and treatment of people with cystic fibrosis and their families. Abstracts for this session were chosen based on their focus on important facets of CF care, presentation of novel concepts, approaches, data or information, and strength of design and implementation. Our aim is to provide the audience with information about current projects that stimulate additional innovation and research efforts within the CF Community.

Learning Objectives:

  • Describe recent efforts in the CF community to develop and test interventions to improve psychosocial outcomes for people with CF.
  • Identify methods to develop and validate quantitative and/or qualitative psychosocial measures for children, young people, and adults with CF.
  • Define strategies for the screening and treatment of anxiety and depression measures in children, young people, and adults with CF.

Presentations:

  • 10:15 AM – 12:15 PM ET
    W10.1- Development of the General Mental Health Screener (GEMS-CF): Identification of common, impactful mental health comorbidities in a diverse sample of adults with cystic fibrosis

    Speaker: Alexandra L. Quittner, PhD (she/her/hers) – Joe DiMaggio Cystic Fibrosis Center

  • 10:15 AM – 12:15 PM ET
    W10.2- Cannabis Use and Self-Reported Symptoms in PwCF

    Speaker: Carla A. Frederick, MD – Cystic Fibrosis Center of Western New York

  • 10:15 AM – 12:15 PM ET
    W10.3- Male Sexual and Reproductive Health in Cystic Fibrosis: A Concept Mapping Study

    Speaker: Kelly A. Prangley, BS (they/them/theirs) – University of Pittsburgh

  • 10:15 AM – 12:15 PM ET
    W10.4- Current suicidality assessment practices and trends in reported death by suicide at US CF Centers

    Speaker: Anna Georgiopoulos, MD (she/her/hers) – Massachusetts General Hospital, Boston, MA, USA

  • 10:15 AM – 12:15 PM ET
    W10.5- Effects of adjusted Elexacaftor/Tezacaftor/Ivacaftor dosing on sleep, behavior, and physical symptoms in young children with cystic fibrosis

    Speaker: Arwen Marker, PhD – Primary Children's CF Center